Evidence map›Paper›PMID 33669120›Full record

ArticleBrain sciences2021

Neuroprotective Effect of α-Mangostin in the Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats.

Aarti Tiwari, Rishabh Khera, Saloni Rahi, Sidharth Mehan, Hafiz Antar Makeen, Yahya H Khormi, Muneeb U Rehman, Andleeb Khan

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
11.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Therapeutic effects ofFrontiers in pharmacology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Plant-mediated green synthesis of gold nanoparticles using an aqueous extract ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Aarti TiwariDepartment of Pharmacology, Neuropharmacology Division, ISF College of Pharmacy, Moga, Punjab 142001, India.
Rishabh KheraDepartment of Pharmacology, Neuropharmacology Division, ISF College of Pharmacy, Moga, Punjab 142001, India.
Saloni RahiDepartment of Pharmacology, Neuropharmacology Division, ISF College of Pharmacy, Moga, Punjab 142001, India.
Sidharth MehanDepartment of Pharmacology, Neuropharmacology Division, ISF College of Pharmacy, Moga, Punjab 142001, India.ORCID 0000-0003-0034-835X
Hafiz Antar MakeenDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
Yahya H KhormiDivision of Neurosurgery, Department of Surgery, Faculty of Medicine, Jazan University, Jazan, 45142, Saudi Arabia.
Muneeb U RehmanDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.ORCID 0000-0002-9995-6576
Andleeb KhanDepartment of Pharmacology & Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.ORCID 0000-0001-6125-3309
Indo Soviet Friendship College of Pharmacy · INJazan University · SAKing Saud University · SA

Funding

ISF College of Pharmacy, Moga (Punjab), India ISFCP/IAEC/CPCSEA/Meeting No.25/2019/Protocol No.409
6 · The paper itself

Abstract

Several studies have documented the role of hyper-activation of extracellular signal-regulated kinases (ERK) in Autism pathogenesis. Alpha-mangostin (AMG) is a phytoconstituents with anti-oxidants, anti-inflammatory, and ERK inhibition properties in many diseases. Our research aims to investigate the neuroprotective effect of AMG in the rat model of intracerebroventricular-propionic acid (ICV-PPA) induced autism with a confirmation of its effect on the ERK signaling. Autism was induced in Wistar rats (total 36 rats; 18 male/18 female) by multiple doses of PPA through ICV injection for 11 days. Actophotometer and beam walking tasks were used to evaluate animals' motor abilities, and the Morris water maze task was utilized to confirm the cognition and memory in animals. Long term administration of AMG 100 mg/kg and AMG 200mg/kg continued from day 12 to day 44 of the experiment. Before that, animals were sacrificed, brains isolated, morphological, gross pathological studies were performed, and neurochemical analysis was performed in the brain homogenates. Cellular and molecular markers, including ERK, myelin basic protein, apoptotic markers including caspase-3, Bax, Bcl-2, neuroinflammatory markers, neurotransmitters, and oxidative stress markers, have been tested throughout the brain. Thus, AMG reduces the overactivation of the ERK signaling and also restored autism-like behavioral and neurochemical alterations.

Indexed as

Autism spectrum disorderERK/mitogen activated protein kinase (MAPK)genetic dysfunctionneuroexcitationpropionic acidα-mangostin

Identifiers

PMID33669120
PMCPMC7996534
OpenAlexW3135056312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.